X4 Pharmaceuticals
#9925
Rank
$18.55M
Marketcap
United States
Country
Mr. Adam S. Mostafa (CFO, Treasurer & Assistant Sec.)
Dr. Paula Ragan Ph.D. (Founder, CEO, Pres, Sec. & Director)
Dr. Murray W. Stewart M.D. (Interim Chief Medical Officer & Director)
Summary
History
X4 Pharmaceuticals was founded in 2015 by biotech veterans who wanted to make a difference in the lives of rare disease patients who lack effective therapies. The company has raised over $150 million in venture funding and is targeting clinical proof-of-concept with its lead program, X4P-001, in serious genetic immunodeficiencies.
Mission
Vision
Key Team
Dr. Richard Peters M.D., Ph.D. (Founder)
Dr. Keith T. Flaherty M.D. (Founder & Member of Corp. Advisory Board)
Dr. Renato T. Skerlj Ph.D. (Founder)
Dr. Mary DiBiase Ph.D. (Chief Operating Officer)
Dr. Arthur Taveras Ph.D. (Chief Scientific Officer)
Dr. Glenn Schulman M.P.H., Pharm. D., Pharm.D. (VP of Investor Relations & Corp. Communications)
Dr. Robert David Arbeit (Sr. VP of Clinical Devel. and Translational Research)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Mr. Adam S. Mostafa (CFO, Treasurer & Assistant Sec.)
Dr. Paula Ragan Ph.D. (Founder, CEO, Pres, Sec. & Director)
Dr. Murray W. Stewart M.D. (Interim Chief Medical Officer & Director)